News & Events
- Calendar of Events
- Lectures & Seminars
- Wall Center Awards & Activities
- Articles/Press Release Archives
2007 VMWC Calendar of Events
November 2008
The 8th Annual Race Against PH
November 2, 2008 at 9 a.m.
Download the Save the Date!
Every other Month
PH Support Group
1st Tuesday of every other month
February, April, June, August, October, December
11:30 – 1:00 pm
Moderator: Allyson Rupp, ACSW, MSW & Lesley Seeger, MSW
Please RSVP to 800.640.WALL (9255)
Wall Center Awards & Activities
2008
Lucille Packard Children's Hospital Hosts Annual Prom Night!
Congratulations to Dr. Marlene Rabinovitch!
- Dr. Marlene Rabinovitch received the American Thoracic Society (ATS) 2008 Recognition Award for Scientific Accomplishment. The Recognition Award is bestowed only upon those with lifelong outstanding scientific contributions to the understanding, prevention, and treatment of lung disease. The award was presented at the ATS International Conference in Toronto on “Novel prospects for the Reversibility of Pulmonary Hypertension.” Congratulations to Dr. Rabinovitch for this well deserved accomplishment.
Articles/Press Releases
Dr. Rabinovitch receives research award from the Cardiovascular Medical Research and Education Fund (CMREF)
Rabinovitch LabDr. Marlene Rabinovitch has received a five year award from the Cardiovascular Medical Research and Education Fund (CMREF). Dr. Rabinovitch and the Wall Center Team, in collaboration with UCSF and the University of Toronto, will serve as a transplant and preparation center studying the lungs from patients with idiopathic pulmonary hypertension (IPAH) as well as secondary forms of pulmonary arterial hypertension and control patients without pulmonary hypertension. To learn more about Dr. Rabinovitch’s research click here.
The Cardiovascular Medical Research and Education Fund was created as a non-profit fund operated solely for charitable, scientific and educational purposes. The CMREF mission is the support of research to uncover the etiology and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH, or PPH), in pursuit of the ultimate goal of its treatment and cure. The immediate objectives are a) to define the cellular basis of IPAH through the study of affected lung tissue, b) to describe the molecular pathways involved in the disease, and c) to identify genetic associations with the IPAH clinical phenotype.
